Last updated: June 2, 2022
Sponsor: Zhejiang Cancer Hospital
Overall Status: Completed
Phase
N/A
Condition
Cervical Cancer
Uterine Disorders
Treatment
N/AClinical Study ID
NCT05410444
ZJCH-RCT
Ages 18-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Older than 18 and younger than 65; ② Have normal independent judgment ability; ③According to the staging standard of International Federation of Obstetrics andgynecology (FIGO) in 2009, the preoperative staging was stage Ⅰ A1 -Ⅱ A2; ④ Patientswho need postoperative radiotherapy according to the provisions of NCCN clinicalpractice guide for cervical cancer in 2015; ⑤ Residual urine volume is more than 100ml.
Exclusion
Exclusion Criteria:
① Extensive hysterectomy with bladder repair; ② Urinary tract infection has occurred at thetime of admission / transfer; ③ Hydronephrosis; ④ Patients with contraindications tointermittent catheterization; ⑤ Do not agree to participate in this clinical study; ⑥Patients with communication difficulties. -
Study Design
Total Participants: 80
Study Start date:
July 01, 2018
Estimated Completion Date:
March 01, 2021
Study Description
Connect with a study center
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China, 310022
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.